BIOBANK Renal Transplantation University Hospitals Leuven
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01331668 |
Recruitment Status :
Recruiting
First Posted : April 8, 2011
Last Update Posted : April 29, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Kidney Failure |
Study Type : | Observational |
Estimated Enrollment : | 5000 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Biobank Renal Transplantation University Hospitals Leuven |
Study Start Date : | March 2004 |
Estimated Primary Completion Date : | December 2099 |
Estimated Study Completion Date : | December 2099 |

Group/Cohort |
---|
renal allograft donors and recipients
All de novo renal allograft recipients transplanted at the University Hospitals Leuven
|
- Renal allograft survival [ Time Frame: 50 years after transplantation ]
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- renal transplant recipients/donors
Exclusion Criteria:
- none

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01331668
Contact: Maarten Naesens, MD, PhD | 32 16344580 | maarten.naesens@uzleuven.be |
Belgium | |
Department of Nephrology and Renal Transplantation - University Hospitals Leuven | Recruiting |
Leuven, BE, Belgium, 3000 | |
Contact: Maarten Naesens, MD, PhD 32 16344580 maarten.naesens@uzleuven.be | |
Principal Investigator: Maarten Naesens, MD, PhD | |
Principal Investigator: Dirk Kuypers, MD, PhD |
Principal Investigator: | Maarten Naesens, MD, PhD | Universitaire Ziekenhuizen Leuven |
Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Prof Dr Maarten Naesens, Prof. Dr. Maarten Naesens, Universitaire Ziekenhuizen Leuven |
ClinicalTrials.gov Identifier: | NCT01331668 |
Other Study ID Numbers: |
TRA-UZL-BIOBANK-001 |
First Posted: | April 8, 2011 Key Record Dates |
Last Update Posted: | April 29, 2020 |
Last Verified: | April 2020 |
Renal Insufficiency Kidney Diseases Urologic Diseases |